Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Mol Hum Reprod ; 26(7): 485-497, 2020 07 01.
Article in English | MEDLINE | ID: mdl-32402064

ABSTRACT

More than 50% of cases of primary ovarian insufficiency (POI) and nonobstructive azoospermia in humans are classified as idiopathic infertility. Meiotic defects may relate to at least some of these cases. Mutations in genes coding for synaptonemal complex (SC) components have been identified in humans, and hypothesized to be causative for the observed infertile phenotype. Mutation SYCE1 c.721C>T (former c.613C>T)-a familial mutation reported in two sisters with primary amenorrhea-was the first such mutation found in an SC central element component-coding gene. Most fundamental mammalian oogenesis events occur during the embryonic phase, and eventual defects are identified many years later, thus leaving few possibilities to study the condition's etiology and pathogenesis. Aiming to validate an approach to circumvent this difficulty, we have used the CRISPR/Cas9 technology to generate a mouse model with an SYCE1 c.721C>T equivalent genome alteration. We hereby present the characterization of the homozygous mutant mice phenotype, compared to their wild type and heterozygous littermates. Our results strongly support a causative role of this mutation for the POI phenotype in human patients, and the mechanisms involved would relate to defects in homologous chromosome synapsis. No SYCE1 protein was detected in homozygous mutants and Syce1 transcript level was highly diminished, suggesting transcript degradation as the basis of the infertility mechanism. This is the first report on the generation of a humanized mouse model line for the study of an infertility-related human mutation in an SC component-coding gene, thus representing a proof of principle.


Subject(s)
DNA-Binding Proteins/metabolism , Nuclear Proteins/genetics , Point Mutation/genetics , Primary Ovarian Insufficiency/genetics , Animals , Chromosome Pairing/genetics , Chromosome Pairing/physiology , DNA-Binding Proteins/genetics , Female , Flow Cytometry , Genetic Predisposition to Disease/genetics , Homozygote , Humans , Immunohistochemistry , Meiosis/genetics , Meiosis/physiology , Mice , Mutation/genetics
2.
Curr Protein Pept Sci ; 18(2): 108-119, 2017.
Article in English | MEDLINE | ID: mdl-27001066

ABSTRACT

Early studies often claimed that autonomic nerves were unimportant for uterine function, since denervation of the uterus had little effects on reproductive success. In 1979, Thorbert wrote, "It seems unlikely that Nature has equipped the uterus with a complex innervation merely as a structural ornament. Our ignorance in this area may be rather due to defects in methods of study". Investigations carried out over the last four decades proved that Thorbert's words were correct, because it is now clear that autonomic and sensory nerves regulate many critical uterine functions. However, the most remarkable aspect of uterine innervation is its capacity to change in response to physiological fluctuations in levels of sex hormones, as those accompanying pregnancy, the sex cycle and puberty. The present review provides an overview about how sex hormones influence uterine innervation. Data are presented about how this physiological plasticity is mimicked by exogenous administration of sex hormones, particularly estrogen. We will review recent developments illustrating the complex multifactorial mechanisms regulating uterine neural plasticity and the nature of molecular signals involved. Finally, we will go through recent findings pointing to the relevance of uterine innervation in gynecological diseases leading to pain and infertility.


Subject(s)
Autonomic Pathways/physiology , Endometriosis/genetics , Estrogens/metabolism , Neuronal Plasticity/genetics , Animals , Autonomic Pathways/metabolism , Endometriosis/metabolism , Endometriosis/pathology , Estrogens/genetics , Female , Leiomyoma/physiopathology , Pregnancy , Signal Transduction , Uterus/innervation , Uterus/metabolism
3.
Vet Parasitol ; 181(2-4): 341-4, 2011 Sep 27.
Article in English | MEDLINE | ID: mdl-21592667

ABSTRACT

The aim of this work was to evaluate the potential of lufenuron, a benzylphenylurea with ability to interfere with the formation of insect exoskeleton, as a therapeutic drug for larval echinococcosis (hydatid disease). For this purpose lufenuron, alone or in combination with albendazole, was administered to CD1 mice bearing Echinococcus granulosus hydatid cysts in the peritoneal cavity. Neither of the drugs alone was able to exert parasiticidal effects. However, in combination with albendazole, lufenuron reduced the growth of cysts (30-40% in cyst diameter respect to control, p<0.05). This effect was associated with ultrastructural alterations of the hydatid cyst wall and a reduction of the content of myo-inositol-hexakisphosphate, the major component of the electron dense granules of the laminated layer. Overall, this work provides evidence that lufenuron could represent a useful compound for the use in chemotherapy against larval echinococcosis, by enhancing albendazole parasiticidal activity.


Subject(s)
Albendazole/therapeutic use , Anthelmintics/therapeutic use , Benzamides/therapeutic use , Echinococcosis/drug therapy , Albendazole/administration & dosage , Animals , Anthelmintics/administration & dosage , Benzamides/administration & dosage , Drug Synergism , Drug Therapy, Combination , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...